Global Peptide Therapeutics Market Survey and Trend Research 2018

May 2018 | 76 pages | ID: G27B3F41E59EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Sanofi, Teva, Novo Nordisk, Takeda, AstraZeneca, AstraZeneca, Novartis, Shire, AbbVie, Ipsen, Allergan, Ferring, Merck, The Medicines, Roche, J & J etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Peptide Therapeutics Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 PEPTIDE THERAPEUTICS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Sanofi (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Teva (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Novo Nordisk (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Takeda (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 AstraZeneca (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 AstraZeneca (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Novartis (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Shire (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 AbbVie (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Ipsen (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Allergan (Company Overview, Sales Data etc.)
4.12 Ferring (Company Overview, Sales Data etc.)
4.13 Merck (Company Overview, Sales Data etc.)
4.14 The Medicines (Company Overview, Sales Data etc.)
4.15 Roche (Company Overview, Sales Data etc.)
4.16 J & J (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Peptide Therapeutics Market 2012-2017, by Type, in USD Million
Table Global Peptide Therapeutics Market 2012-2017, by Type, in Volume
Table Global Peptide Therapeutics Market Forecast 2018-2023, by Type, in USD Million
Table Global Peptide Therapeutics Market Forecast 2018-2023, by Type, in Volume
Table Sanofi Overview List
Table Peptide Therapeutics Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Peptide Therapeutics Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Peptide Therapeutics Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Overview List
Table Peptide Therapeutics Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Peptide Therapeutics Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Peptide Therapeutics Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Peptide Therapeutics Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Overview List
Table Peptide Therapeutics Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Peptide Therapeutics Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen Overview List
Table Peptide Therapeutics Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Peptide Therapeutics Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ferring Overview List
Table Peptide Therapeutics Business Operation of Ferring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Peptide Therapeutics Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table The Medicines Overview List
Table Peptide Therapeutics Business Operation of The Medicines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Peptide Therapeutics Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table J & J Overview List
Table Peptide Therapeutics Business Operation of J & J (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Peptide Therapeutics Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Peptide Therapeutics Sales Revenue Share, by Companies, in USD Million
Table Global Peptide Therapeutics Sales Volume 2012-2017, by Companies, in Volume
Table Global Peptide Therapeutics Sales Revenue Share, by Companies in 2017, in Volume
Table Peptide Therapeutics Demand 2012-2017, by Application, in USD Million
Table Peptide Therapeutics Demand 2012-2017, by Application, in Volume
Table Peptide Therapeutics Demand Forecast 2018-2023, by Application, in USD Million
Table Peptide Therapeutics Demand Forecast 2018-2023, by Application, in Volume
Table Global Peptide Therapeutics Market 2012-2017, by Region, in USD Million
Table Global Peptide Therapeutics Market 2012-2017, by Region, in Volume
Table Peptide Therapeutics Market Forecast 2018-2023, by Region, in USD Million
Table Peptide Therapeutics Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Peptide Therapeutics Industry Chain Structure
Figure Global Peptide Therapeutics Market Growth 2012-2017, by Type, in USD Million
Figure Global Peptide Therapeutics Market Growth 2012-2017, by Type, in Volume
Figure Global Peptide Therapeutics Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Peptide Therapeutics Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region